As a result, the FDA added several warnings to the drugs label for suicidal thoughts and behaviors, eye disorders that could lead to permanent vision loss, decreased sweating with an elevated body temperature and increased risks for high levels of acid in the blood
Clinical observations suggest that women using weight loss injections may experience restoration of regular menstrual cycles and improved ovulation rates as metabolic parameters normalize, though individual responses vary considerably and timing is unpredictable
Sci Rep 15:3688
D., Dobbin M
Not yet commercially available Retatrutide is currently in Phase 3 clinical trials and has not yet received regulatory approval for commercial prescribing in the UK
Kovacs, P., Lehn-Stefan, A., Stumvoll, M., Bogardus, C